Breast cancer laterality and molecular subtype likely share a common risk factor
Received 1 August 2018
Accepted for publication 19 October 2018
Published 29 November 2018 Volume 2018:10 Pages 6549—6554
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Rituraj Purohit
Shao-Ang Cheng,1,* Li-Zhong Liang,2,* Qi-Lian Liang,1 Zhen-Yi Huang,3 Xiao-Xia Peng,1 Xiao-Cui Hong,1 Xing-Bo Luo,1 Gao-Le Yuan,1 Hui-Jie Zhang,1 Liang Jiang4
1Oncology Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China; 2Medical Insurance Office, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China; 3Department of Finance, Central Hospital of Guangdong Agriculture Reclamation, Zhanjiang 524002, China; 4Interventional Ward, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China
*These authors contributed equally to this work
Background: To investigate the epidemiological features of breast cancer laterality and molecular subtypes in southern China.
Materials and methods: A total of 2,049 cases who were diagnosed with unilateral breast cancer in the past 5 years were classified based on laterality and molecular subtypes. Molecular subtypes were defined in accordance with the 2013 St. Gallen recommendations.
Results: Breast cancer was more likely to be diagnosed in the left breast than in the right at a rate of around 5%. In the case of invasive carcinomas, the right breast was more commonly affected than the left in young (<40 years old) patients (left-to-right [L:R] ratio 0.80, 95% CI 0.65, 0.98), whereas the opposite trend was found in old (≥40 years old) patients (L:R ratio 1.06, 95% CI 1.02, 1.73). Except for invasive mucinous and invasive medullary breast cancers, the other histological types occurred more frequently on the left side than on the right. In situ cancer with a defined subtype was likely to be diagnosed as luminal B(HER-2+). Except for invasive medullary and invasive nonspecific cancers, other invasive carcinomas with a defined subtype were most likely to be diagnosed as luminal B(HER-2–). The age of ≥40 years was a risk factor for luminal B(HER-2+), and a significant correlation was present between the right breast and luminal B(HER-2+).
Conclusion: We explored the risk factors of breast cancer laterality and various molecular subtypes and found that age may be a predictor of breast cancer laterality. We found that age and laterality are the probable risk factors of the luminal B(HER-2+) type of breast cancer. These results provide a basis for the epidemiological characterization of breast cancer.
Keywords: epidemiology, breast carcinoma, tumor laterality, molecular subtype, histological type, risk factor, China
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]